Bluelight Therapeutics, Inc.
Records under this name other than patents Bluelight Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Bluelight Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,395,358 | Methods for detecting allosteric modulators of protein Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,932,822 | Methods for detecting allosteric modulators of protein Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,383,361 | Methods for detecting allosteric modulators of protein Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,938,560 | Methods for identifying modulators of Ras using nonlinear techniques Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,451,630 | Systems and methods for high throughput analysis of conformation in biological entities Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,768,174 | Attachment of proteins to interfaces for use in nonlinear optical detection Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,989,534 | Systems and methods for high throughput analysis of conformation in biological entities Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,486,881 | Methods and devices for detection of peripheral membrane protein interactions using nonlinear optical techniques Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,880,172 | Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability Lapsed on the fee record Ended Jan 30, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 30, 2026 | USPTO record |
| US 9,428,789 | Classification of kinase inhibitors using nonlinear optical techniques Lapsed on the fee record Ended Aug 30, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 30, 2024 | USPTO record |